Bausch Health Companies Inc's stock is experiencing a notable drop, raising concerns among investors.
Bausch Health Companies Inc (BHC.TO) has seen its stock slide by 4.58% in today’s trading session, closing at CA$8.65. This decline follows a brief period of optimism after a strong second-quarter earnings report that initially boosted investor confidence.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.61B
52W high
$11.97
52W low
$6.10
1W change
+41.72%
Beta
0.38
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 22.7% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-22.7% Upside
Current Price
C$9.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
95.5%
Annualized
90-Day Vol
64.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$10.84
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.63 | C$6.92 – C$13.38 |
| 60 trading days | C$10.22 | C$6.41 – C$16.28 |
| 90 trading days | C$10.84 | C$6.13 – C$19.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should remain cautious as Bausch Health's recent performance reflects ongoing volatility and uncertainty about its long-term recovery strategy.
Bausch Health's stock down 4.58% today
The market cap of Bausch Health currently stands at CA$3.61 billion, highlighting the company's significant valuation despite recent struggles.
Bull case
Even though the stock is down now, Bausch Health's recent earnings report showed a promising turnaround. After the announcement, the stock price jumped 28%, suggesting there’s potential for recovery if management can execute their plans well.
Bear case
This year has not been kind to Bausch Health, with the stock down about 32.7%. Additionally, recent hedge fund participation has decreased, indicating that institutional confidence is waning. This trend suggests that the company may face more challenges ahead.
Recent Performance Overview
Advertisement
Bausch Health's stock has been on a rollercoaster ride, recently climbing 28% after a strong Q2 earnings report. However, today's decline of 4.58% raises questions about the sustainability of this momentum. With a market cap of CA$3.61 billion, the stock's volatility is a point of concern for investors.
Investor Sentiment and Hedge Fund Activity
Investor sentiment appears to be shifting as hedge fund participation in Bausch Health has dropped significantly, indicating a lack of confidence in the company's ability to maintain profitability. This decline in institutional interest could further pressure the stock in the near term, especially given its 32.7% year-to-date loss.
Looking Ahead: What’s Next for Bausch Health?
As Bausch Health navigates its recovery, investors will be closely watching management's strategy and any updates on its performance. The company's ability to execute its plans effectively will be crucial in determining whether the stock can regain its footing or continue to slide.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
